The Oral Hypoglycemic Agents (OHAs) market was valued at USD 61.20 Billion in 2022 and is expected to reach USD 83.75 Billion by 2030, growing at a CAGR of 4% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market